These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23479137)

  • 1. Minor role of pregnane-x-receptor for acquired multidrug resistance in head and neck squamous cell carcinoma in vitro.
    Rigalli JP; Reuter T; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J; Theile D
    Cancer Chemother Pharmacol; 2013 May; 71(5):1335-43. PubMed ID: 23479137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma.
    Theile D; Gal Z; Warta R; Rigalli JP; Lahrmann B; Grabe N; Herold-Mende C; Dyckhoff G; Weiss J
    Cancer Biol Ther; 2014 Apr; 15(4):436-42. PubMed ID: 24448417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pregnane X receptor (PXR) and the nuclear receptor corepressor 2 (NCoR2) modulate cell growth in head and neck squamous cell carcinoma.
    Rigalli JP; Reichel M; Reuter T; Tocchetti GN; Dyckhoff G; Herold-Mende C; Theile D; Weiss J
    PLoS One; 2018; 13(2):e0193242. PubMed ID: 29470550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma.
    Theile D; Ketabi-Kiyanvash N; Herold-Mende C; Dyckhoff G; Efferth T; Bertholet V; Haefeli WE; Weiss J
    Head Neck; 2011 Jul; 33(7):959-68. PubMed ID: 20737486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of EGFR in the response of squamous cell carcinoma of the head and neck cell lines to gefitinib.
    Taguchi T; Tsukuda M; Imagawa-Ishiguro Y; Kato Y; Sano D
    Oncol Rep; 2008 Jan; 19(1):65-71. PubMed ID: 18097577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.
    Chen Y; Huang W; Chen F; Hu G; Li F; Li J; Xuan A
    Cancer Med; 2016 Dec; 5(12):3564-3571. PubMed ID: 27878971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    Mol Pharmacol; 2007 Oct; 72(4):1045-53. PubMed ID: 17636047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
    Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
    Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Terada A; Hyodo I; Ogawa T; Fukushima M
    Oncology; 2007; 73(1-2):104-11. PubMed ID: 18337622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Approaches to Study Regulation of Hepatic Cytochrome P450 (CYP) 3A Expression by Paclitaxel and Rifampicin.
    Ghose R; Mallick P; Taneja G; Chu C; Moorthy B
    Methods Mol Biol; 2016; 1395():55-68. PubMed ID: 26910068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
    Kothari V; Mulherkar R
    Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
    Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines.
    Mensah-Osman EJ; Thomas DG; Tabb MM; Larios JM; Hughes DP; Giordano TJ; Lizyness ML; Rae JM; Blumberg B; Hollenberg PF; Baker LH
    Cancer; 2007 Mar; 109(5):957-65. PubMed ID: 17279585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CD147 contributes to the chemoresistance of head and neck squamous cell carcinoma cells.
    Huang Z; Wang L; Wang Y; Zhuo Y; Li H; Chen J; Chen W
    J Oral Pathol Med; 2013 Aug; 42(7):541-6. PubMed ID: 23413783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of NR1I2 (pregnane X receptor) polymorphisms in head and neck squamous cell carcinoma.
    Reuter T; Warta R; Theile D; Meid AD; Rigalli JP; Mogler C; Herpel E; Grabe N; Lahrmann B; Plinkert PK; Herold-Mende C; Dyckhoff G; Haefeli WE; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Nov; 388(11):1141-50. PubMed ID: 26141049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.